Suscribirse

Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis - 11/09/11

Doi : 10.1016/S0022-3476(97)70025-8 
Mary Corey, PhD, Lloyd Edwards, PhD, Henry Levison, MD, Michael Knowles, MD

Abstract

Background: Chronic progressive lung disease is the most prominent cause of morbidity and death in patients with cystic fibrosis (CF), but severity of lung disease and rate of lung function decline are widely variable. Accurate estimates of decline have been difficult to define and compare because the timing of measurements and duration of follow-up differ in various patient groups.

Patients: Three hundred sixty-six patients with CF, born from 1960 to 1974, were selected from a CF database birth cohort if they had two or more measurements of pulmonary function, at least one of which was performed before the age of 10 years.

Methods: Mixed model regression analysis provided estimates of the average rate of decline of spirometry measurements in subgroups on the basis of survival age, sex, pancreatic status, and genotype.

Results: Patients who died before the age of 15 years had significantly poorer pulmonary function when first tested and a more rapid decline in pulmonary function thereafter than patients who survived beyond the age of 15 years. In the latter, functional levels at the age of 5 years were normal, but average rates of decline were significantly related to survival age. Female patients had significantly steeper decline than male patients, and those with pancreatic insufficiency had much steeper decline than those with pancreatic sufficiency. In the subset of 197 who survived to 1990 and were subsequently genotyped, rate of decline was greater in those homozygous for the ΔF508 mutation, compared with those who were heterozygous for ΔF508 or those who had two other mutations.

Discussion: All but the most severely affected patients, who died before age 15, appear to have had normal pulmonary function when first tested in early childhood. Pancreatic sufficiency, male gender, and some non-ΔF508 mutations are associated with a slower rate of pulmonary function decline. Mixed model analysis is a valuable tool for describing and comparing pulmonary function decline in groups of patients with CF. (J Pediatr 1997;131:809-14)

El texto completo de este artículo está disponible en PDF.

Abbreviations : CF, FEF25-75, FEV1, FVC, HSC, PI, PS


Esquema


 Supported by research grants from the Canadian Cystic Fibrosis Foundation and the Medical Research Council of Canada.
 Reprint requests: Mary Corey, PhD, Division of Gastroenterology and Nutrition, The Hospital for Sick Children, 555 University Ave., Toronto, Ontario, M5G 1X8 Canada.
 9/21/83366


© 1997  Mosby, Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 131 - N° 6

P. 809-814 - décembre 1997 Regresar al número
Artículo precedente Artículo precedente
  • “Feeding the gut”: The scientific basis for continued enteral nutrition during acute diarrhea
  • Christopher Duggan, Samuel Nurko
| Artículo siguiente Artículo siguiente
  • Carbon 13–labeled urea breath test for the diagnosis of Helicobacter pylori infection in children
  • Marion Rowland, Imelda Lambert, Siobhan Gormally, Leslie E. Daly, Julian E. Thomas, Clive Hetherington, Marie Durnin, Brendan Drumm

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.